TY  - GEN
AU  - Smith,C R
AU  - Ambinder,R
AU  - Lipsky,J J
AU  - Petty,B G
AU  - Israel,E
AU  - Levitt,R
AU  - Mellits,E D
AU  - Rocco,L
AU  - Longstreth,J
AU  - Lietman,P S
TI  - Cefotaxime compared with nafcillin plus tobramycin for serious bacterial infections. A randomized, double-blind trial
SN  - 0003-4819
PY  - 1984///1010
KW  - Adult
KW  - Aged
KW  - Bacterial Infections
KW  - drug therapy
KW  - Cefotaxime
KW  - adverse effects
KW  - Clinical Trials as Topic
KW  - Double-Blind Method
KW  - Drug Therapy, Combination
KW  - Enterobacter
KW  - Enterobacteriaceae Infections
KW  - Escherichia coli Infections
KW  - Female
KW  - Humans
KW  - Infusions, Parenteral
KW  - Kidney Diseases
KW  - chemically induced
KW  - Male
KW  - Middle Aged
KW  - Nafcillin
KW  - administration & dosage
KW  - Penicillin Resistance
KW  - Prognosis
KW  - Pseudomonas Infections
KW  - Random Allocation
KW  - Tobramycin
KW  - Urinary Tract Infections
N1  - Publication Type: Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.7326/0003-4819-101-4-469
ER  -